Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Mostra altre versioni (1)

Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer�...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A
Altri autori:	International College of Geriatric Psychoneuropharmacology
Natura:	Journal article
Lingua:	English
Pubblicazione:	John Wiley & Sons, Ltd. 2010
Soggetti:	Medical sciences Psychiatry

Documenti analoghi

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
di: Oulhaj, A, et al.
Pubblicazione: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
di: Smith, A, et al.
Pubblicazione: (2010)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
di: de Jager, C, et al.
Pubblicazione: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
di: De Jager, C, et al.
Pubblicazione: (2012)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
di: Goodwin, G
Pubblicazione: (2003)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
di: Goodwin, G
Pubblicazione: (2003)

Homocysteine, B vitamins, and cognitive impairment
di: Smith, A, et al.
Pubblicazione: (2016)

Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people – Effects of sex and APOEe4
di: Matteo Spinedi, et al.
Pubblicazione: (2024-02-01)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
di: Smith, A, et al.
Pubblicazione: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
di: Smith, A, et al.
Pubblicazione: (2010)

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
di: Ines Elisabeth Futschek, et al.
Pubblicazione: (2023-02-01)

Homocysteine, B vitamins, and cardiovascular disease
di: Refsum, H, et al.
Pubblicazione: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
di: Refsum, H, et al.
Pubblicazione: (2006)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
di: Ballard, C, et al.
Pubblicazione: (2008)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
di: Oulhaj, A, et al.
Pubblicazione: (2016)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
di: Martins, C, et al.
Pubblicazione: (2005)

Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism
di: Fullerton, J, et al.
Pubblicazione: (2003)

High dimensional endophenotype ranking in the search for major depression risk genes
di: Glahn, D, et al.
Pubblicazione: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
di: De Jager, C, et al.
Pubblicazione: (2012)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
di: Clarke, R, et al.
Pubblicazione: (1998)

MET and autism susceptibility: family and case-control studies
di: Sousa, I, et al.
Pubblicazione: (2009)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
di: Jones, S, et al.
Pubblicazione: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
di: A David Smith, et al.
Pubblicazione: (2010-09-01)

Investigating circadian disruption in mouse models of neurological and metabolic disorders
di: Livieratos, A
Pubblicazione: (2013)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
di: Belbin, O, et al.
Pubblicazione: (2009)

How can magnetoencephalography and magnetic resonance imaging improve our understanding of genetic susceptibility to Alzheimer's disease?
di: Heise, V
Pubblicazione: (2013)

Psychiatric, demographic and personality characteristics of elderly sex offenders
di: Fazel, S, et al.
Pubblicazione: (2002)

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
di: Geetika Nehra, et al.
Pubblicazione: (2025-01-01)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
di: Olivia M. Osborne, et al.
Pubblicazione: (2023-08-01)

The cognitive neuropsychology of depression in the elderly
di: Herrmann, L, et al.
Pubblicazione: (2007)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
di: Nurk, E, et al.
Pubblicazione: (2005)

Using neuroimaging and histology to understand hyperexcitability and atypical connectivity in autism spectrum disorder
di: Ravishankar, M
Pubblicazione: (2015)

Effect of physical activity on anxiety and depression in COVID-19 adults: A systematic review and meta-analysis
di: Qingyuan Luo, et al.
Pubblicazione: (2024-10-01)

Caregiver Burden is Associated with Cognitive Decline and Physical Disability of Elderly Post-Stroke Patients
di: Othman, Zahiruddin, et al.
Pubblicazione: (2014)

Validation of the Malay Version of Short Informant Questionnaire on Cognitive Decline in the Elderly (MS-IQCODE)
di: Othman, Zahiruddin, et al.
Pubblicazione: (2015)

QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
di: Sermin Kesebir, et al.
Pubblicazione: (2018-08-01)

Alzheimer's Disease - A Comprehensive Review
di: Kinga Woźniak, et al.
Pubblicazione: (2024-02-01)

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study
di: Luigi Zerbinati, et al.
Pubblicazione: (2022-10-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
di: Refsum, H, et al.
Pubblicazione: (2006)

Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition
di: Olga Włoczkowska, et al.
Pubblicazione: (2021-01-01)